Abstract
Methotrexate (MTX) is a disease-modifying anti-rheumatic and anti-folate drug which inhibits dihydrofolic acid reductase.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Biomedical Journal of Scientific & Technical Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.